Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fernando Cabanillas, MD
M.D. Anderson Cancer Center
Principal Investigator - Leonard Klein, MD
Illinois Cancer Specialists - US Oncology
Principal Investigator - Petros Nikolinakos, MD
Northeast Georgia Cancer Care
Principal Investigator - Steven E Finkelstein, MD
GenesisCare USA
Principal Investigator - Steven Jubelirer, MD
West Virginia University
Principal Investigator - Thomas Witzig, MD
The Mayo Clinic & Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- 21st Century Oncology
Sun City, Arizona, United States
- Northeast Georgia Cancer Care
Athens, Georgia, United States
- Illinois Cancer Specialists
Niles, Illinois, United States
- Park Nicollet Institute
Saint Louis Park, Minnesota, United States
- Charleston Area Medical Center
Charleston, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Dec 2012
- Primary completion
- 5 Mar 2013
- Completion
- 5 Mar 2013
- Last update posted
- 4 Oct 2021
- Registered enrollment
- 1
- Registry id
- NCT01662102
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.